Hibiscrub (Chlorhexidine Gluconate)

Hibiscrub is used as a broad‑spectrum skin antiseptic in several clinical and non‑clinical situations. It helps reduce microbial load on the skin before invasive procedures and supports routine hygiene for health‑care workers.

• Pre‑operative skin preparation to lower the risk of surgical site infections.
• Hand hygiene for health‑care personnel and other individuals in contact‑intensive environments.
• Cleansing of minor cuts, abrasions, and superficial wounds.
• Disinfection of skin before catheter insertion or other minor invasive procedures.
• General skin decontamination in community or institutional settings.

• Chlorhexidine gluconate, the active component of Hibiscrub, exerts its antiseptic effect by binding to negatively charged bacterial cell walls and disrupting membrane integrity. This interaction leads to leakage of intracellular contents and precipitation of cytoplasmic proteins, ultimately causing irreversible cell damage and death. The compound is active against a wide range of Gram‑positive and Gram‑negative bacteria, as well as some fungi and viruses, providing broad‑spectrum antimicrobial activity on the skin surface.

Adverse reactions to Hibiscrub are generally mild but can vary in severity.

Common

• Transient skin irritation or redness at the application site.
• Mild itching or burning sensation.
• Dryness or peeling of the treated skin.
• Contact dermatitis in sensitive individuals.

Serious

• Severe allergic reaction (e.g., urticaria, angioedema, anaphylaxis).
• Persistent or worsening skin irritation that does not resolve after discontinuation.
• Rare cases of chemical burns with prolonged or excessive exposure.
• Systemic toxicity is extremely uncommon but may occur with extensive application over large body surface areas.

When using Hibiscrub, follow these safety considerations to minimize risks.

• Avoid application to mucous membranes, eyes, or deep puncture wounds.
• Do not use on patients with known hypersensitivity to chlorhexidine or related compounds.
• Test a small skin area first if the user has a history of skin sensitivities.
• Keep the product out of reach of children and store at room temperature away from direct sunlight.
• Discontinue use and seek medical advice if severe irritation or allergic symptoms develop.
• Use only as directed; excessive or prolonged application may increase the likelihood of irritation.

While Hibiscrub is applied topically, certain substances can affect its safety or efficacy.

Avoid

• Concurrent use of other topical antiseptics containing alcohol or iodine on the same area, which may increase irritation.
• Application over skin pre‑treated with strong irritants or corrosive agents.

Use with caution

• Topical corticosteroids or immunosuppressive creams, which may mask irritation signs.
• Occlusive dressings that trap the product and increase skin exposure.
• Patients receiving systemic chlorhexidine (e.g., catheter lock solutions), to avoid cumulative exposure.
• Use on compromised skin integrity in patients with extensive burns or dermatitis, monitoring closely for adverse reactions.